Hecht Curtis

Avg. Two Year Performance

No purchase track record

48% Avg. Sale Return

22% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	12%	5%	20%	57%	48%
Sale Success Rate	3 of 4	3 of 4	3 of 4	4 of 4	3 of 4

Calithera Biosciences, Inc.

Drugs » Biotechnology

CHIEF BUSINESS OFFICER:

Holdings: 92.32K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--